Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 6
2009 6
2010 19
2011 11
2012 14
2013 7
2014 4
2015 3
2016 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Recent clinical experience with oncolytic viruses.
Donnelly OG, Errington-Mais F, Prestwich R, Harrington K, Pandha H, Vile R, Melcher AA. Donnelly OG, et al. Curr Pharm Biotechnol. 2012 Jul;13(9):1834-41. doi: 10.2174/138920112800958904. Curr Pharm Biotechnol. 2012. PMID: 21740364 Review.
Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses.
Rajani K, Parrish C, Kottke T, Thompson J, Zaidi S, Ilett L, Shim KG, Diaz RM, Pandha H, Harrington K, Coffey M, Melcher A, Vile R. Rajani K, et al. Mol Ther. 2016 Feb;24(1):166-74. doi: 10.1038/mt.2015.156. Epub 2015 Aug 27. Mol Ther. 2016. PMID: 26310630 Free PMC article.
The hitchhiker's guide to virotherapy.
Donnelly O, Vile R, Pandha H, Harrington K, Melcher A. Donnelly O, et al. Oncotarget. 2012 Aug;3(8):735-6. doi: 10.18632/oncotarget.627. Oncotarget. 2012. PMID: 22964541 Free PMC article. No abstract available.
Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy.
Blanchard M, Shim KG, Grams MP, Rajani K, Diaz RM, Furutani KM, Thompson J, Olivier KR, Park SS, Markovic SN, Pandha H, Melcher A, Harrington K, Zaidi S, Vile R. Blanchard M, et al. Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):577-87. doi: 10.1016/j.ijrobp.2015.07.2274. Epub 2015 Jul 26. Int J Radiat Oncol Biol Phys. 2015. PMID: 26461000 Free PMC article.
The biology of the sodium iodide symporter and its potential for targeted gene delivery.
Hingorani M, Spitzweg C, Vassaux G, Newbold K, Melcher A, Pandha H, Vile R, Harrington K. Hingorani M, et al. Curr Cancer Drug Targets. 2010 Mar;10(2):242-67. doi: 10.2174/156800910791054194. Curr Cancer Drug Targets. 2010. PMID: 20201784 Free PMC article. Review.
Oncolytic viruses: a novel form of immunotherapy.
Prestwich RJ, Harrington KJ, Pandha HS, Vile RG, Melcher AA, Errington F. Prestwich RJ, et al. Expert Rev Anticancer Ther. 2008 Oct;8(10):1581-8. doi: 10.1586/14737140.8.10.1581. Expert Rev Anticancer Ther. 2008. PMID: 18925850 Free PMC article. Review.
Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?
Pencavel T, Seth R, Hayes A, Melcher A, Pandha H, Vile R, Harrington KJ. Pencavel T, et al. Gene Ther. 2010 Aug;17(8):949-60. doi: 10.1038/gt.2010.48. Epub 2010 May 6. Gene Ther. 2010. PMID: 20445580 Free PMC article. Review.
Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics.
Harrington KJ, Vile RG, Melcher A, Chester J, Pandha HS. Harrington KJ, et al. Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):91-8. doi: 10.1016/j.cytogfr.2010.02.006. Epub 2010 Mar 12. Cytokine Growth Factor Rev. 2010. PMID: 20223697 Free PMC article. Review.
Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents.
Zaidi S, Blanchard M, Shim K, Ilett E, Rajani K, Parrish C, Boisgerault N, Kottke T, Thompson J, Celis E, Pulido J, Selby P, Pandha H, Melcher A, Harrington K, Vile R. Zaidi S, et al. Mol Ther. 2015 May;23(5):845-856. doi: 10.1038/mt.2014.253. Epub 2014 Dec 29. Mol Ther. 2015. PMID: 25544599 Free PMC article.
Cell carriers for oncolytic viruses: Fed Ex for cancer therapy.
Willmon C, Harrington K, Kottke T, Prestwich R, Melcher A, Vile R. Willmon C, et al. Mol Ther. 2009 Oct;17(10):1667-76. doi: 10.1038/mt.2009.194. Epub 2009 Aug 18. Mol Ther. 2009. PMID: 19690519 Free PMC article. Review.
60 results
Jump to page